Retatrutide vs. Tirzepatide vs. Semaglutide: What Can the Research Actually Tell Us?
TLDR Retatrutide, tirzepatide, and semaglutide act on different combinations of metabolic hormone receptors. Semaglutide: GLP-1 receptor agonist. Tirzepatide: GIP + GLP-1 receptor agonist. Retatrutide: GIP + GLP-1 + glucagon receptor agonist. In separate obesity trials without diabetes, semaglutide produced about 14.9% average weight loss at 68 weeks in STEP 1, tirzepatide produced up to 20.9% … Read more